Sign In
Buy QGEN
$37.56
+1.11 (+3.05%)
At Close: Jun 04, 2026
Qiagen reports first-quarter beat thanks to growth in non-COVID-19 products
04:30pm, Monday, 03'rd May 2021
U.S.-German genetic testing specialist Qiagen reported slightly better-than-expected quarterly earnings on Monday as sales growth for non-coronavirus products added to high demand for its COVID-19 tes
HILDEN, Germany & SALUGGIA, Italy--(BUSINESS WIRE)--QIAGEN with DiaSorin, announce the launch of LIAISON® LymeDetect® Assay based on QuantiFERON technology for early diagnosis of Lyme Borreliosis
QIAGEN Launches artus Prep&Amp as CE-Marked SARS-CoV-2 Test Offering up to Threefold Increase in Daily Lab Testing Capacity
04:05pm, Tuesday, 20'th Apr 2021
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN launches artus Prep&Amp as CE-marked SARS-CoV-2 test offering up to threefold increase in daily lab testing capacity
QIAGEN N.V. to Report First Quarter 2021 Results
05:55am, Tuesday, 20'th Apr 2021
VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN N.V. to Report First Quarter 2021 Results
Here's Why You Should Hold on to QIAGEN (QGEN) Stock for Now
08:37am, Monday, 19'th Apr 2021
Investors continue to be optimistic about QIAGEN (QGEN) on the back of product launches and impressive geographical growth.
QGEN vs. TECH: Which Stock Should Value Investors Buy Now?
12:52pm, Thursday, 08'th Apr 2021
QGEN vs. TECH: Which Stock Is the Better Value Option?
3 GARP MedTech Stocks to Snap Up Despite Pandemic Woes
08:20am, Thursday, 08'th Apr 2021
Here we look at three stocks, OMI, HOLX and QGEN, that investors can add to their watchlist backed by robust long-term prospects.
QIAGEN (QGEN) Launches QIAseq Kit, Enhances COVID-19 Portfolio
10:36am, Wednesday, 07'th Apr 2021
QIAGEN's (QGEN) latest kit is likely to significantly reduce library turnaround times and plastics usage, thus allowing more accurate detection and quantification of molecular variants.
QIAGEN Adds to COVID-19 Portfolio With New Ultra-Fast Sequencing Solution for High-Throughput Genomic Surveillance
04:05pm, Tuesday, 06'th Apr 2021
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN adds to COVID-19 portfolio with new ultra-fast sequencing solution for high-throughput genomic surveillance
QIAGEN's (QGEN) NeuMoDx Multiplex Test Receives FDA EUA
09:06am, Thursday, 01'st Apr 2021
QIAGEN's (QGEN) new NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage test strengthens the company's portfolio in PCR testing, while becoming a crucial diagnostic tool for the flu season and the pandemic.
QIAGEN Receives FDA Emergency Use Authorization for NeuMoDx Multiplex Test Expanding COVID-19 Portfolio
02:00am, Monday, 29'th Mar 2021
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN receives FDA Emergency Use Authorization for NeuMoDx multiplex test expanding COVID-19 portfolio
Here's Why You Should Hold on to QIAGEN (QGEN) Stock for Now
12:53pm, Tuesday, 16'th Mar 2021
Investors continue to be optimistic about QIAGEN (QGEN) on robust segmental and geographical growth.
QIAGEN (QGEN) Unveils Digital Platform for Syndromic Testing
05:28pm, Friday, 05'th Mar 2021
QIAGEN's (QGEN) QIAsphere cloud-based platform will enhance QIAstat-Dx's potential by offering remote services round the clock to improve testing continuity.
QIAGEN Announces 20-F Annual Report Filing for 2020 Results
06:05am, Friday, 05'th Mar 2021
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)---- $QGEN--QIAGEN announces 20-F annual report filing for 2020 results
QIAGEN Launches QIAsphere Cloud-Based Connectivity Solution to Enhance QIAstat-Dx Capabilities in Digital Diagnostics
04:10pm, Wednesday, 03'rd Mar 2021
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)---- $QGEN--QIAGEN launches QIAsphere cloud-based connectivity solution to enhance QIAstat-Dx capabilities in digital diagnostics
